SFL.MI
Strong BuyFull HouseAI screen passSafilo Group S.p.A. · Healthcare · Italy · $786M
EUR 1.85 +0.1% · close 7 Oct · scored 9 Oct
Full House: Strong business, sensible price, market agrees. The rare full house.
Read our full research report on SFL.MI (Apr 2026), freeDoes StockRank work? Each month we publish how every decile did, whichever way it went. See the record →
Passes quantitative hurdles with solid scores and benefits from clear management conviction signals through recent director buying and strong upward EPS revisions.
ABOUT SAFILO GROUP S.P.A.
Read
Safilo Group S.p.A. designs, manufactures, and distributes eyewear, including prescription frames and sunglasses, for its own brands like Carrera and Polaroid, as well as numerous licensed luxury and fashion brands. The company leverages its Italian design expertise and a global distribution network, offering a strong portfolio of eyewear products. Safilo is a significant global player in the eyewear industry.
FINANCIAL SUMMARY (EUR)
| Year | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 969.6M | 1.1B | 1.0B | 993.2M | 983.4M | 0.4% | 963.8M | 979.9M | 1.0B | 2.2% |
| EPS (EUR) | — | 0.13 | -0.06 | 0.05 | 0.12 | -3.7% | 0.12 | 0.15 | 0.15 | 13.7% |
| Shares | — | 413.7M | 413.7M | 403.2M | 392.0M | -5.2% | 388.5M | — | — | — |
| Debt | — | 191.1M | 157.6M | 130.1M | 98.3M | -19.9% | 79.6M | — | — | — |
| Equity | — | 409.9M | 379.2M | 413.1M | 392.5M | -1.4% | — | — | — | — |
| Op CF | — | 9.2M | 47.7M | 76.2M | 89.7M | 114.0% | 128.6M | — | — | — |
| Inv CF | — | -15.7M | -8.6M | -48.9M | -23.6M | — | — | — | — | — |
| Fin CF | — | -16.8M | -40.5M | -54.8M | -58.6M | — | — | — | — | — |
Swung more than 54% of stocks we rank over the past year (44% a year).
How this is worked out
What it measures: day-to-day price moves over the past year, as a yearly figure, ranked against every stock we cover. Very calm under 20% a year, Calm 20 to 30%, Average 30 to 40%, Bumpy 40 to 55%, Very bumpy above that.
What we found: across about 13,500 stocks in 34 markets (2002 to 2025), past swings were a good guide to the next year's, and bumpier stocks fell further. How much further changed too much between eras to put a number on it.
Calm is not safe: a calm stock can still slide steadily.
Rules fixed before any data was fetched. Describes the chart, not a recommendation.
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of SFL.MI are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| SFL.MI | Safilo Group S.p.A.(you) | $786M | 95 | Strong Buy |
| STVN | Stevanato Group S.p.A. | $5.9B | 59 | Hold |
| PHIL.MI | Philogen S.p.A. | $1.0B | 100 | Strong Buy |
| ELN.MI | EL.En. S.p.A. | $1.4B | 85 | Strong Buy |
| GHC.MI | Garofalo Health Care S.p.A. | $542M | 78 | Buy |
| PHN.MI | Pharmanutra S.p.A. | $771M | 71 | Buy |
| GPI.MI | GPI S.p.A. | $474M | 61 | Hold |
| DIA.MI | DiaSorin S.p.A. | $4.4B | 84 | Strong Buy |
| AMP.MI | Amplifon S.p.A. | $3.6B | 78 | Buy |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.3B | 88 | Strong Buy |
Peer medians: ROE 9.1% · P/E 25.2x · Gross margin 50.3%
Company Deep Dive
Read the full research report: business segments breakdown, earnings transcripts review, management credibility analysis, competitive landscape, and scenarios.